Such Ca2+ entry pathway appears to be mediated by Orai3 in estrogen receptor-positive breast cancer and non-small cell lung carcinoma cells, whereas the “classical” STIM1/Orai1 pathway predominates in estrogen receptor-negative breast cancer cells [72,73]. The gene discussed is ESR1; the disease is non-small cell lung carcinoma.